Skip to content
Dose Brief
Menu
No. 70 here · Grade C

MyDrHank review

A six-shelf prescription telehealth catalog whose GLP-1 price genuinely holds flat as you titrate — but whose every advertised figure is a twelve-month prepay rate, with the month-to-month price published nowhere.

Visit MyDrHank Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
$259/mo (month-to-month; prepay tiers lower)
Tirzepatide
$349/mo (month-to-month; prepay tiers lower)
Coverage
44 states (not KS, LA, MS, NM, ND, WV)
Brand-name
Compounded only
On the trackerNewnew to the tracker, no prior readingFirst reading. The funnel advertises "from $240" tirzepatide and "from $171" semaglutide; both are twelve-month prepay rungs, and the month-to-month rates — $349 and $259 — appear on no page of it.

The scorecard

MyDrHank scored on our six Brief Score factors. See the methodology.

Price Stability80/100
Supply Reliability78/100
Transparency62/100
Access Breadth76/100
Clinical Oversight74/100
Track Record72/100

What we like

  • The GLP-1 price is dose-flat and the desk says so in terms — "The price stays the same at every dose — no surprise price increases" — so titrating to a maintenance dose does not raise the bill
  • The prepay tiers are real and steep if you can fund them up front: compounded tirzepatide $2,883 for twelve months ($240/mo) against $349 month-to-month, injectable semaglutide $2,140 ($178/mo) against $259, oral semaglutide $2,057 ($171/mo) against $249
  • An oral semaglutide route on the same account at $249/mo month-to-month — a needle-free option most desks in this ranking do not offer at all
  • Prices are published in full before any intake quiz, with all four term rungs and their up-front totals shown
  • Clean against the FDA warning-letter database under brand, corporate entity and domain, and "Dr. Hank, LLC" is credited in the site's own privacy policy and terms of use — most desks in this tier credit no legal entity anywhere

The caveats

  • Every "From $X/mo" the funnel displays is the twelve-month prepay rung, because the price display is a min() over the term ladder — so the month-to-month rate you would actually pay is rendered on no page of the site
  • One footnote advertises a plan that exists at no tier: "Plans start at $171/mo for compounded semaglutide and $200/mo for compounded tirzepatide." No tirzepatide rung costs $200, and that $171 is the ORAL product's yearly rate — injectable semaglutide's is $178
  • The FAQ describes a twelve-month prepay rate as a plan with "no contract"
  • No served-states list is published anywhere on the consumer site; the six exclusions above come from the affiliate program's terms, not from anything a reader can look up
  • Compounded only — no FDA-approved Wegovy or Zepbound pathway — and no compounding pharmacy is named beyond "an FDA-registered U.S. pharmacy"
  • On the NAD+ nasal spray, the headline "6x increase in whole blood NAD+" is sourced to a randomized trial of ORAL NMN rather than to this product
  • The dose-flat price promise is GLP-1 only — the NAD+ and sermorelin lines say the opposite, that "final pricing depends on the protocol and dose prescribed"

The brief

Best for: Readers who already intend to prepay a year up front and want one account covering GLP-1 alongside NAD+, sermorelin and four other lines — and who will check the term attached to a price before treating it as a monthly bill. A six-shelf prescription telehealth catalog whose GLP-1 price genuinely holds flat as you titrate — but whose every advertised figure is a twelve-month prepay rate, with the month-to-month price published nowhere.

Ranked #70 of 509 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Closest here

The desks scoring nearest MyDrHank — the realistic shortlist if you're weighing it.

Weighing MyDrHank against one desk in particular? We file it head to head with our top-ranked pick in CoreAge Rx vs MyDrHank, and every desk that outranks it is listed on the MyDrHank alternatives ranking.

More desks we track (24)

478 more are filed too — see every desk we track, ranked.

Pricing, states and verification reflect MyDrHank's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on MyDrHank's site. Not medical advice; see our disclosure.

← Back to all rankings